Welcome to LookChem.com Sign In|Join Free
  • or
C17H25BO5 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1429323-80-7

Post Buying Request

1429323-80-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1429323-80-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1429323-80-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,9,3,2 and 3 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1429323-80:
(9*1)+(8*4)+(7*2)+(6*9)+(5*3)+(4*2)+(3*3)+(2*8)+(1*0)=157
157 % 10 = 7
So 1429323-80-7 is a valid CAS Registry Number.

1429323-80-7Relevant academic research and scientific papers

Biphenyl compound as well as preparation method and medical application thereof

-

Paragraph 0938; 0942; 0949-0950, (2020/11/22)

The invention discloses a biphenyl compound as well as a preparation method and medical application thereof, the structure of the biphenyl compound is shown as a formula (I) or a formula (II), and thebiphenyl compound or pharmaceutically acceptable salt, tautomer, meso-isomer, raceme, stereoisomer, metabolite, metabolite precursor, prodrug or solvate thereof is a PD-L1 inhibitor. The compound hasa remarkable inhibiting effect on the interaction of PD-1 and PD-L1 protein, so that the compound can be applied to the preparation of PD-L1 inhibitors and immunomodulator drugs for preventing or treating tumors, autoimmune diseases, organ transplant rejection, infectious diseases and inflammatory diseases.

MACROCYCLIC LRRK2 KINASE INHIBITORS

-

Page/Page column 80; 81, (2013/04/13)

The present invention relates to novel macrocylic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of LRRK2 (Leucine-Rich Repeat Kinase 2). Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine or diagnostic agent, in particular for the treatment and/or diagnosis of diseases characterized by LRRK2 kinase activity such as neurological disorders including Parkinson's disease and Alzheimer's disease

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1429323-80-7